FDA approves Medtech’s ROSA Spine robot : 5 things to know

Medtech received 510(k) clearance from the FDA to market the ROSA Spine robot in the United States.

Advertisement

Here are five things to know:

 

1. The ROSA Spine robot received the CE Mark in 2014.

 

2. It is currently being used in minimally invasive spine surgery.

 

3. The first commercial procedure in Europe was performed in December 2014.

 

4. In 2012, the ROSA platform was approved in America for brain surgery.

 

5. There are currently 27 ROSA Brain systems installed in U.S. facilities.

 

More articles on devices:
CBS News highlights spinal cord stimulation for back pain: 3 points
5 key trends in the global orthopedic biomaterials market
New spinal fusion system going to human trials in Australia: 5 key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.